Skip to main content
Top
Published in: Annals of Surgical Oncology 2/2024

10-12-2023 | ASO Author Reflections

ASO Author Reflections: Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) for Platinum-Resistance Ovarian Cancer Patients

Authors: Giuseppe Vizzielli, PhD, Maria Teresa Giudice, MD, Anna Fagotti, PhD, Giovanni Scambia, MD

Published in: Annals of Surgical Oncology | Issue 2/2024

Login to get access

Excerpt

Despite the advances in cytoreductive efforts and the potential addition of bevacizumab and poly(ADP)-ribose polymerase (PARP) inhibitors to front-line platinum-based regimens, the vast majority of patients with advanced ovarian cancer relapse. …
Literature
1.
go back to reference Berek JS, Renz M, Kehoe S, Kumar L, Friedlander M. Cancer of the ovary, fallopian tube, and peritoneum: 2021 update. Int J Gynaecol Obstet. 2021;155(Suppl 1):61–85.CrossRefPubMedPubMedCentral Berek JS, Renz M, Kehoe S, Kumar L, Friedlander M. Cancer of the ovary, fallopian tube, and peritoneum: 2021 update. Int J Gynaecol Obstet. 2021;155(Suppl 1):61–85.CrossRefPubMedPubMedCentral
2.
go back to reference Tempfer CB, Winnekendonk G, Solass W, et al. Pressurized intraperitoneal aerosol chemotherapy in women with recurrent ovarian cancer: a phase 2 study. Gynecol Oncol. 2015;137(2):223–8.CrossRefPubMed Tempfer CB, Winnekendonk G, Solass W, et al. Pressurized intraperitoneal aerosol chemotherapy in women with recurrent ovarian cancer: a phase 2 study. Gynecol Oncol. 2015;137(2):223–8.CrossRefPubMed
3.
go back to reference Horvath P, Yurttas C, Baur I, et al. Current medical care situation of patients in germany undergoing pressurized intraperitoneal aerosol chemotherapy (PIPAC). Cancers. 2022;14(6):1443.CrossRefPubMedPubMedCentral Horvath P, Yurttas C, Baur I, et al. Current medical care situation of patients in germany undergoing pressurized intraperitoneal aerosol chemotherapy (PIPAC). Cancers. 2022;14(6):1443.CrossRefPubMedPubMedCentral
Metadata
Title
ASO Author Reflections: Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) for Platinum-Resistance Ovarian Cancer Patients
Authors
Giuseppe Vizzielli, PhD
Maria Teresa Giudice, MD
Anna Fagotti, PhD
Giovanni Scambia, MD
Publication date
10-12-2023
Publisher
Springer International Publishing
Published in
Annals of Surgical Oncology / Issue 2/2024
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-023-14770-z

Other articles of this Issue 2/2024

Annals of Surgical Oncology 2/2024 Go to the issue